Allen, Alexander R.

Normotensive individuals who show a robust pressor response to sympathoexcitatory stimuli are at increased risk for developing hypertension. In healthy young adults, we defined a cumulative pressor score (CPS) as the mean increase in systolic arterial pressure across 3 stressors: mental stress, cold pressor test (CPT), and isometric handgrip to fatigue (HG). We hypothesized that individuals with high CPS would possess other physiologic traits associated with cardiovascular reactivity. In 143 subjects (M/F: 57/86, ages 18–40 yr) quartiles were formed with hyper‐responders (CPS ≥ 27.0 mmHg) in the top and hypo‐responders (≤ 16.6 mmHg) in the bottom quartile. Comparisons across quartiles included age, sex, BMI, arterial catecholamines at rest and during stress, HR variability, baroreflex sensitivity by modified Oxford, pulse wave velocity, and 24‐hr ambulatory BP measures. Age was associated with CPS, as hyper‐responders (mean age±SE: 29±1 yr) were approximately 4 yrs older than each quartile (p<0.01). Hypo‐responders had decreased norepinephrine during CPT (p<0.01) and HG (p<0.01), and epinephrine during HG (p<0.01) when compared to each quartile. No other physiologic variable was associated with CPS or quartile. These findings imply that while hyper‐responders may be at greatest cardiovascular risk, it appears to be a consequence of normal aging, as few other intermediate physiologic markers of BP reactivity were associated with pressor scores. Support: HL‐089331, CTSA RR‐024150

Dietary sodium influences intermediate physiological traits in healthy young adults independent of changes in blood pressure. The purpose of this study was to test the hypothesis that dietary sodium affects cardiac autonomic function. In prospective, randomized cross‐over design separated by 1 month or more between diets, 69 normotensive healthy young adults (M/F: 26/43, ages 18–38 yr) consumed a 5‐day low (10 mmol/day), normal (150 mmol), and high sodium (400mmol) diet prior to a protocol examining cardiovascular traits including heart rate variability (HRV) by time domain and frequency domain analysis (Nevrokard). All women were studied in the low hormone phase of the menstrual cycle. Diet did not affect blood pressure, but HR (mean ± SE) was 68±1, 65±1, and 64±1 in low, normal, and high sodium conditions, resp. (RM ANOVA p < 0.01). For HRV there was a main effect of sodium on SDNN, RMSSD, HF, LFnu, HFnu, and LF/HF ratio (p < 0.01 for all). The response to low sodium was most marked and consistent with sympathetic activation, with increased LFnu and LF/HF ratio, and decreased SDNN, RMSSD, and HFnu compared to both normal and high sodium conditions (p ≤ 0.05 for all). These findings suggest that autonomic control of HRV is altered through changes in dietary sodium without changes in blood pressure. Support: UL1 TR000135 , HL‐89331

We examined the effects of acute β‐adrenergic blockade on central artery hemodynamics and wave reflection characteristics in young healthy humans. High‐fidelity radial artery waveforms were recorded non‐invasively by applanation tonometry before and after intravenous propranolol (0.25 mg/kg bolus for 5 min followed by a maintenance infusion of 0.004/mg/kg/min for 20–30 min) in fourteen subjects (9 F/5M; 27 ± 2 years). Radial blood pressure (BP) was calibrated from the brachial BP (arterial catheter). Aortic augmentation index (AI a ; a measure of amplitude and timing of arterial pressure wave reflection) and roundtrip travel time of the reflected wave to and from the periphery (Δt p ; inverse of pulse wave velocity) were calculated from the generated aortic pressure waveform and are indices of central arterial stiffness. Systemic β‐blockade reduced heart rate (HR; 60 ± 2 vs. 53 ± 2 bpm, P < 0.001) and increased AI a (9.9 ± 4.3% vs. 4.3 ± 4.4%, P < 0.05), but did not alter Δt p (156 ± 4 msec vs. 152 ± 2 msec, P = 0.34). The AI a normalized to a HR of 75bpm (AI a @75) was not increased following β‐blockade (P = 0.67). Taken together, our data indicate that the increase in AI a following systemic β‐blockade is a result of a slower HR and not due to changes in β‐ mediated vascular tone. Supported by NIH K23 DK‐082424 (TBC), AHA 2170087(ECH) and CTSA RR‐024150

AimA major feature of endothelial dysfunction is reduced endothelium‐dependent vasodilation, which in ageing may be due to decreased production of endothelial prostacyclin, or nitric oxide (NO), or both.MethodWe tested this hypothesis in 12 younger (age 18–38 years, six women) and 12 older healthy adults (age 55–73 years, six post‐menopausal women). Endothelium‐dependent vasodilation was assessed by the forearm vascular conductance (FVC) response to intra‐arterial acetylcholine (ACh) (0.5, 1.0, 2.0, 4.0 μg dl−1forearm tissue min−1) before and 90 min after inhibition of the enzyme cyclo‐oxygenase‐2 (COX‐2) with oral celecoxib (400 mg), followed by the addition of endothelialNOsynthase inhibition with intra‐arterialNG‐monomethyl‐l arginine acetate (L‐NMMA).ResultsAgeing was associated with a significantly reducedFVCresponse toACh(P= 0.009, age‐by‐dose interaction; highest doseFVC±SEMin ageing: 11.2 ± 1.4vs.younger: 17.7 ± 2.4 units,P= 0.02). Celecoxib did not reduce restingFVCor the responses toAChin any group.L‐NMMAsignificantly reduced restingFVCand the responses toAChin all groups, and absoluteFVCvalues followingL‐NMMAwere similar between groups.ConclusionIn healthy normotensive younger and older adults, there is minimal contribution of prostacyclin toACh‐mediated vasodilation, yet theNOcomponent of vasodilation is reduced with ageing. In the clinical context, these findings suggest that acute administration of medications that inhibit prostacyclin (i.e.COX‐2 inhibitors) evoke modest vascular consequences in healthy persons. Additional studies are necessary to test whether chronic use ofCOX‐2 medications reduces endothelium dependent vasodilation in older persons with or without cardiovascular risk factors.